Transthyretin Market Report

Global Transthyretin Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：232
  • REPORT CODE：GMM838640
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Transthyretin market report explains the definition, types, applications, major countries, and major players of the Transthyretin market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Pfizer Inc

    • Regeneron Pharmaceuticals Inc

    • Neurimmune Holding AG

    • Alnylam Pharmaceuticals Inc

    • Prothena Corp Plc

    • Arcturus Therapeutics Inc

    • Ionis Pharmaceuticals Inc

    By Type:

    • AG-10

    • ALN-TTRsc02

    • CRX-1008

    • EDE-1307

    • Inotersen Sodium

    • Others

    By End-User:

    • Familial Amyloid Neuropathies

    • Alzheimer's Disease

    • Cardomyopathy

    • Neuropathy

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Transthyretin Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Transthyretin Outlook to 2028- Original Forecasts

    • 2.2 Transthyretin Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Transthyretin Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Transthyretin Market- Recent Developments

    • 6.1 Transthyretin Market News and Developments

    • 6.2 Transthyretin Market Deals Landscape

    7 Transthyretin Raw Materials and Cost Structure Analysis

    • 7.1 Transthyretin Key Raw Materials

    • 7.2 Transthyretin Price Trend of Key Raw Materials

    • 7.3 Transthyretin Key Suppliers of Raw Materials

    • 7.4 Transthyretin Market Concentration Rate of Raw Materials

    • 7.5 Transthyretin Cost Structure Analysis

      • 7.5.1 Transthyretin Raw Materials Analysis

      • 7.5.2 Transthyretin Labor Cost Analysis

      • 7.5.3 Transthyretin Manufacturing Expenses Analysis

    8 Global Transthyretin Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Transthyretin Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Transthyretin Export by Region (Top 10 Countries) (2017-2028)

    9 Global Transthyretin Market Outlook by Types and Applications to 2022

    • 9.1 Global Transthyretin Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global AG-10 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global ALN-TTRsc02 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global CRX-1008 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global EDE-1307 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Inotersen Sodium Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Transthyretin Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Familial Amyloid Neuropathies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Alzheimer's Disease Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cardomyopathy Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Neuropathy Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Transthyretin Market Analysis and Outlook till 2022

    • 10.1 Global Transthyretin Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Transthyretin Consumption (2017-2022)

      • 10.2.2 Canada Transthyretin Consumption (2017-2022)

      • 10.2.3 Mexico Transthyretin Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Transthyretin Consumption (2017-2022)

      • 10.3.2 UK Transthyretin Consumption (2017-2022)

      • 10.3.3 Spain Transthyretin Consumption (2017-2022)

      • 10.3.4 Belgium Transthyretin Consumption (2017-2022)

      • 10.3.5 France Transthyretin Consumption (2017-2022)

      • 10.3.6 Italy Transthyretin Consumption (2017-2022)

      • 10.3.7 Denmark Transthyretin Consumption (2017-2022)

      • 10.3.8 Finland Transthyretin Consumption (2017-2022)

      • 10.3.9 Norway Transthyretin Consumption (2017-2022)

      • 10.3.10 Sweden Transthyretin Consumption (2017-2022)

      • 10.3.11 Poland Transthyretin Consumption (2017-2022)

      • 10.3.12 Russia Transthyretin Consumption (2017-2022)

      • 10.3.13 Turkey Transthyretin Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Transthyretin Consumption (2017-2022)

      • 10.4.2 Japan Transthyretin Consumption (2017-2022)

      • 10.4.3 India Transthyretin Consumption (2017-2022)

      • 10.4.4 South Korea Transthyretin Consumption (2017-2022)

      • 10.4.5 Pakistan Transthyretin Consumption (2017-2022)

      • 10.4.6 Bangladesh Transthyretin Consumption (2017-2022)

      • 10.4.7 Indonesia Transthyretin Consumption (2017-2022)

      • 10.4.8 Thailand Transthyretin Consumption (2017-2022)

      • 10.4.9 Singapore Transthyretin Consumption (2017-2022)

      • 10.4.10 Malaysia Transthyretin Consumption (2017-2022)

      • 10.4.11 Philippines Transthyretin Consumption (2017-2022)

      • 10.4.12 Vietnam Transthyretin Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Transthyretin Consumption (2017-2022)

      • 10.5.2 Colombia Transthyretin Consumption (2017-2022)

      • 10.5.3 Chile Transthyretin Consumption (2017-2022)

      • 10.5.4 Argentina Transthyretin Consumption (2017-2022)

      • 10.5.5 Venezuela Transthyretin Consumption (2017-2022)

      • 10.5.6 Peru Transthyretin Consumption (2017-2022)

      • 10.5.7 Puerto Rico Transthyretin Consumption (2017-2022)

      • 10.5.8 Ecuador Transthyretin Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Transthyretin Consumption (2017-2022)

      • 10.6.2 Kuwait Transthyretin Consumption (2017-2022)

      • 10.6.3 Oman Transthyretin Consumption (2017-2022)

      • 10.6.4 Qatar Transthyretin Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Transthyretin Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Transthyretin Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Transthyretin Consumption (2017-2022)

      • 10.7.2 South Africa Transthyretin Consumption (2017-2022)

      • 10.7.3 Egypt Transthyretin Consumption (2017-2022)

      • 10.7.4 Algeria Transthyretin Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Transthyretin Consumption (2017-2022)

      • 10.8.2 New Zealand Transthyretin Consumption (2017-2022)

    11 Global Transthyretin Competitive Analysis

    • 11.1 Pfizer Inc

      • 11.1.1 Pfizer Inc Company Details

      • 11.1.2 Pfizer Inc Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Pfizer Inc Transthyretin Main Business and Markets Served

      • 11.1.4 Pfizer Inc Transthyretin Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Regeneron Pharmaceuticals Inc

      • 11.2.1 Regeneron Pharmaceuticals Inc Company Details

      • 11.2.2 Regeneron Pharmaceuticals Inc Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Regeneron Pharmaceuticals Inc Transthyretin Main Business and Markets Served

      • 11.2.4 Regeneron Pharmaceuticals Inc Transthyretin Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Neurimmune Holding AG

      • 11.3.1 Neurimmune Holding AG Company Details

      • 11.3.2 Neurimmune Holding AG Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Neurimmune Holding AG Transthyretin Main Business and Markets Served

      • 11.3.4 Neurimmune Holding AG Transthyretin Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Alnylam Pharmaceuticals Inc

      • 11.4.1 Alnylam Pharmaceuticals Inc Company Details

      • 11.4.2 Alnylam Pharmaceuticals Inc Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Alnylam Pharmaceuticals Inc Transthyretin Main Business and Markets Served

      • 11.4.4 Alnylam Pharmaceuticals Inc Transthyretin Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Prothena Corp Plc

      • 11.5.1 Prothena Corp Plc Company Details

      • 11.5.2 Prothena Corp Plc Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Prothena Corp Plc Transthyretin Main Business and Markets Served

      • 11.5.4 Prothena Corp Plc Transthyretin Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Arcturus Therapeutics Inc

      • 11.6.1 Arcturus Therapeutics Inc Company Details

      • 11.6.2 Arcturus Therapeutics Inc Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Arcturus Therapeutics Inc Transthyretin Main Business and Markets Served

      • 11.6.4 Arcturus Therapeutics Inc Transthyretin Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Ionis Pharmaceuticals Inc

      • 11.7.1 Ionis Pharmaceuticals Inc Company Details

      • 11.7.2 Ionis Pharmaceuticals Inc Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Ionis Pharmaceuticals Inc Transthyretin Main Business and Markets Served

      • 11.7.4 Ionis Pharmaceuticals Inc Transthyretin Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    12 Global Transthyretin Market Outlook by Types and Applications to 2028

    • 12.1 Global Transthyretin Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global AG-10 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global ALN-TTRsc02 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global CRX-1008 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global EDE-1307 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Inotersen Sodium Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Transthyretin Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Familial Amyloid Neuropathies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Alzheimer's Disease Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Cardomyopathy Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Neuropathy Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Transthyretin Market Analysis and Outlook to 2028

    • 13.1 Global Transthyretin Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Transthyretin Consumption Forecast (2022-2028)

      • 13.2.2 Canada Transthyretin Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Transthyretin Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Transthyretin Consumption Forecast (2022-2028)

      • 13.3.2 UK Transthyretin Consumption Forecast (2022-2028)

      • 13.3.3 Spain Transthyretin Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Transthyretin Consumption Forecast (2022-2028)

      • 13.3.5 France Transthyretin Consumption Forecast (2022-2028)

      • 13.3.6 Italy Transthyretin Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Transthyretin Consumption Forecast (2022-2028)

      • 13.3.8 Finland Transthyretin Consumption Forecast (2022-2028)

      • 13.3.9 Norway Transthyretin Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Transthyretin Consumption Forecast (2022-2028)

      • 13.3.11 Poland Transthyretin Consumption Forecast (2022-2028)

      • 13.3.12 Russia Transthyretin Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Transthyretin Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Transthyretin Consumption Forecast (2022-2028)

      • 13.4.2 Japan Transthyretin Consumption Forecast (2022-2028)

      • 13.4.3 India Transthyretin Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Transthyretin Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Transthyretin Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Transthyretin Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Transthyretin Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Transthyretin Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Transthyretin Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Transthyretin Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Transthyretin Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Transthyretin Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Transthyretin Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Transthyretin Consumption Forecast (2022-2028)

      • 13.5.3 Chile Transthyretin Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Transthyretin Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Transthyretin Consumption Forecast (2022-2028)

      • 13.5.6 Peru Transthyretin Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Transthyretin Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Transthyretin Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Transthyretin Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Transthyretin Consumption Forecast (2022-2028)

      • 13.6.3 Oman Transthyretin Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Transthyretin Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Transthyretin Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Transthyretin Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Transthyretin Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Transthyretin Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Transthyretin Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Transthyretin Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Transthyretin Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Transthyretin Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Transthyretin

    • Figure of Transthyretin Picture

    • Table Global Transthyretin Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Transthyretin Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global AG-10 Consumption and Growth Rate (2017-2022)

    • Figure Global ALN-TTRsc02 Consumption and Growth Rate (2017-2022)

    • Figure Global CRX-1008 Consumption and Growth Rate (2017-2022)

    • Figure Global EDE-1307 Consumption and Growth Rate (2017-2022)

    • Figure Global Inotersen Sodium Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Familial Amyloid Neuropathies Consumption and Growth Rate (2017-2022)

    • Figure Global Alzheimer's Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Cardomyopathy Consumption and Growth Rate (2017-2022)

    • Figure Global Neuropathy Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Transthyretin Consumption by Country (2017-2022)

    • Table North America Transthyretin Consumption by Country (2017-2022)

    • Figure United States Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Canada Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Mexico Transthyretin Consumption and Growth Rate (2017-2022)

    • Table Europe Transthyretin Consumption by Country (2017-2022)

    • Figure Germany Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure UK Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Spain Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Belgium Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure France Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Italy Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Denmark Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Finland Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Norway Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Sweden Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Poland Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Russia Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Turkey Transthyretin Consumption and Growth Rate (2017-2022)

    • Table APAC Transthyretin Consumption by Country (2017-2022)

    • Figure China Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Japan Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure India Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure South Korea Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Thailand Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Singapore Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Philippines Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Transthyretin Consumption and Growth Rate (2017-2022)

    • Table South America Transthyretin Consumption by Country (2017-2022)

    • Figure Brazil Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Colombia Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Chile Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Argentina Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Peru Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Transthyretin Consumption and Growth Rate (2017-2022)

    • Table GCC Transthyretin Consumption by Country (2017-2022)

    • Figure Bahrain Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Oman Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Qatar Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Transthyretin Consumption and Growth Rate (2017-2022)

    • Table Africa Transthyretin Consumption by Country (2017-2022)

    • Figure Nigeria Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure South Africa Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Egypt Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure Algeria Transthyretin Consumption and Growth Rate (2017-2022)

    • Table Oceania Transthyretin Consumption by Country (2017-2022)

    • Figure Australia Transthyretin Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Transthyretin Consumption and Growth Rate (2017-2022)

    • Table Pfizer Inc Company Details

    • Table Pfizer Inc Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Transthyretin Main Business and Markets Served

    • Table Pfizer Inc Transthyretin Product Portfolio

    • Table Regeneron Pharmaceuticals Inc Company Details

    • Table Regeneron Pharmaceuticals Inc Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Regeneron Pharmaceuticals Inc Transthyretin Main Business and Markets Served

    • Table Regeneron Pharmaceuticals Inc Transthyretin Product Portfolio

    • Table Neurimmune Holding AG Company Details

    • Table Neurimmune Holding AG Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neurimmune Holding AG Transthyretin Main Business and Markets Served

    • Table Neurimmune Holding AG Transthyretin Product Portfolio

    • Table Alnylam Pharmaceuticals Inc Company Details

    • Table Alnylam Pharmaceuticals Inc Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alnylam Pharmaceuticals Inc Transthyretin Main Business and Markets Served

    • Table Alnylam Pharmaceuticals Inc Transthyretin Product Portfolio

    • Table Prothena Corp Plc Company Details

    • Table Prothena Corp Plc Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Prothena Corp Plc Transthyretin Main Business and Markets Served

    • Table Prothena Corp Plc Transthyretin Product Portfolio

    • Table Arcturus Therapeutics Inc Company Details

    • Table Arcturus Therapeutics Inc Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arcturus Therapeutics Inc Transthyretin Main Business and Markets Served

    • Table Arcturus Therapeutics Inc Transthyretin Product Portfolio

    • Table Ionis Pharmaceuticals Inc Company Details

    • Table Ionis Pharmaceuticals Inc Transthyretin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ionis Pharmaceuticals Inc Transthyretin Main Business and Markets Served

    • Table Ionis Pharmaceuticals Inc Transthyretin Product Portfolio

    • Figure Global AG-10 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ALN-TTRsc02 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CRX-1008 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global EDE-1307 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Inotersen Sodium Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Familial Amyloid Neuropathies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Alzheimer's Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardomyopathy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neuropathy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Transthyretin Consumption Forecast by Country (2022-2028)

    • Table North America Transthyretin Consumption Forecast by Country (2022-2028)

    • Figure United States Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Transthyretin Consumption Forecast by Country (2022-2028)

    • Figure Germany Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Transthyretin Consumption Forecast by Country (2022-2028)

    • Figure China Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Transthyretin Consumption Forecast by Country (2022-2028)

    • Figure Brazil Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Transthyretin Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Transthyretin Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Transthyretin Consumption Forecast by Country (2022-2028)

    • Figure Australia Transthyretin Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Transthyretin Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US